4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-239240
Chief Operating Officer sold 2,176 shares at $19.00 ($41,344)
- Chief Operating Officer acquired 2,176 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Champoux Jennifer · Chief Operating Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-22 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,176 | $3.98 | $8,660 | 64,547 | D |
| 2026-05-22 | Sale : show line 2 in the form 10b5-1 | −2,176 | $19.00 | $41,344 | 62,371 | D |
| Open-market sales · 2,176 sh · avg $19.00 · $41,344 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-22 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −2,176 | 37,824 | D |
Loading xslF345X06/ownership.xml…